A checkpoint inhibitor gains FDA approval in endometrial cancer
On April 22, 2021, the US Food and Drug Administration (FDA) granted Accelerated Approval to dostarlimab (Jemperli, GlaxoSmithKline) as...
Recent developments in primary hyperoxaluria treatment
Primary hyperoxaluria (PH) is a rare genetic disease in which high levels of oxalate are produced and can deposit...
FDA Approves First Trial of CRISPR for Sickle Cell Disease
The U.S Food and Drug Administration (FDA) has approved the first clinical trial of CRISPR to correct sickle cell...
Circadian Clock Protein CRY1 – The Novel Target for Prostate Cancer
Prostate cancer is one of the most common cancers and a second leading cause of cancer death in American...
CAR-T Therapy Approved for B-Cell Non-Hodgkin Lymphoma
Non-Hodgkin lymphoma treatment traditionally relied on chemotherapy, radiation, and bone marrow transplant. More recently, immuno-oncology treatments have come to...
CRISPR-Based Diagnostics on the Rise
In 2020, the Nobel Prize in Chemistry was awarded for “the development of a method for genome editing” based...
Can the Stages of Chronic Kidney Disease (CKD) be Reversed?
Chronic kidney disease (CKD), a global public issue is associated with substantial morbidity and mortality. In the past few...
Breast Cancer Awareness Month: What should people know about breast cancer?
Breast cancer remains to be the most common malignancy in women and places second on the causes of morbidity...
Cleft Palate and Cleft Lip: A congenital malformation
According to the World Health Organization (WHO), it is estimated that 1 out of 700 newborn babies are born...
COVID-19, Latest Stats, Strategies adopted by Italy, US & India : The Way Forward
The novel coronavirus (nCoV-19) or the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a new public health crisis...